Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfonylurea continuation, discontinuation, and low-dose rechallenge in type 2 diabetes with sulfonylurea failure
TCTR20170525001Completed
- Start
- Feb 2008
- Countries
- 1
01
Overview
Open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by None. Primary endpoints: Beta-cell function during sulfonylurea treatment and after sulfonylurea withdrawal, Insulin resistance assessed by OGTT and 1 more. Started Feb 2008; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20170525001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170525001.